...
首页> 外文期刊>Journal of medicinal food >Hepatoprotective Activity of an Herbal Composition, MAP, a Standardized Blend Comprising Myristica fragrans, Astragalus membranaceus, and Poria cocos
【24h】

Hepatoprotective Activity of an Herbal Composition, MAP, a Standardized Blend Comprising Myristica fragrans, Astragalus membranaceus, and Poria cocos

机译:草药组合物,MAP,包含肉豆蔻,黄芪和Por的标准化混合物的保肝活性

获取原文
获取原文并翻译 | 示例
           

摘要

Historically, botanicals have been reported to possess good antioxidative activities as demonstrated by their free radical scavenging property rendering their usage in liver protection. In this study, we describe the potential use of MAP, a standardized blend comprising three extracts from Myristica fragrans, Astragalus membranaceus, and Poria cocos, in ameliorating chemically induced acute liver toxicities. Acetaminophen (APAP) and carbon tetrachloride (CCl4)-induced acute liver toxicity models in mice were utilized. Hepatic functional tests from serum collected at T24, histopathology analysis, and merit of blending three standardized extracts were evaluated. MAP administered at doses of 150-400mg/kg showed statistically significant and dose-correlated inhibitions of serum alanine aminotransferase (ALT) ranging from 30.8% (P.05) to 88.1% (P=.0001) in the APAP and 66.9% (P=.002) to 83.7% (P=.0002) in the CCl4 models, respectively. Moreover, MAP resulted in up to 75.7%, 60.9%, and 33.3% reductions in serum aspartate aminotransferase (AST), bile acid, and total bilirubin, respectively. Mice treated with oral doses of composition of MAP at 300mg/kg showed statistically significant reduction in hepatocyte necrosis when compared with vehicle control. Unexpected synergistic protection of liver damage was also observed. Therefore, the composition, MAP, could be potentially utilized as an effective hepatic detoxifying agent for the protection of liver damage.
机译:历史上,据报道植物药具有良好的抗氧化活性,其自由基清除性能证明了其在肝脏保护中的用途。在这项研究中,我们描述了MAP的潜在用途,该混合物包括从肉豆蔻,黄芪和Por中提取的三种提取物,可改善化学诱导的急性肝毒性。利用对乙酰氨基酚(APAP)和四氯化碳(CCl4)诱导的小鼠急性肝毒性模型。评估了在T24收集的血清的肝功能测试,组织病理学分析以及混合三种标准化提取物的优点。 MAP剂量为150-400mg / kg时,APAP对血清丙氨酸氨基转移酶(ALT)的抑制作用具有统计学意义,与剂量相关,范围从30.8%(P.05)到88.1%(P = .0001),在APAP中为66.9%( P = .002)到CCl4模型中的83.7%(P = .0002)。此外,MAP可使血清天冬氨酸转氨酶(AST),胆汁酸和总胆红素分别降低75.7%,60.9%和33.3%。与媒介物对照相比,口服剂量为300mg / kg的MAP组合物治疗的小鼠显示肝细胞坏死的统计学显着减少。还观察到了对肝损伤的意外的协同保护作用。因此,该组合物MAP可潜在地用作保护肝脏损害的有效肝解毒剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号